REG - Abbott Laboratories - Statement of Changes in Director/PDMR Shareholding <Origin Href="QuoteRef">ABT.N</Origin>

Abbott LaboratoriesAnnouncement

03/10/2016 10:40

RNS Number : 1451L
Abbott Laboratories
28 September 2016
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM




1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Michael J. Warmuth

2.
Reason for the notification
a)
Position / status
Executive Vice President, Established Pharmaceuticals
b)
Initial notification / amendment
Initial Notification

3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Abbott Laboratories

b)
LEI
HQD377W2YR662HK5JX27


4.
Details of the transaction(s)
Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument 
Common Shares without par value

Identification code
US0028241000
b)
Nature of the transaction
Gifts of ABT stock
c)

Price(s)
Volume(s)
USD 0
12,152
d)
Aggregated information

- Aggregated volume

- Price

e)
Date of the transaction
2016-08-31
f)
Place of the transaction
New York Stock Exchange (XNYS)




5
Details of the transaction(s)
Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument 


Identification code

b)
Nature of the transaction

c)

Price(s)
Volume(s)


d)
Aggregated information

- Aggregated volume

- Price

e)
Date of the transaction

f)
Place of the transaction


This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHEAFNPAFXKEAF